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Abstract
Background: The ONCO-i2b2 platform is a bioinformatics tool designed to integrate clinical and research data and
support translational research in oncology. It is implemented by the University of Pavia and the IRCCS Fondazione
Maugeri hospital (FSM), and grounded on the software developed by the Informatics for Integrating Biology and
the Bedside (i2b2) research center. I2b2 has delivered an open source suite based on a data warehouse, which is
efficiently interrogated to find sets of interesting patients through a query tool interface.
Methods: Onco-i2b2 integrates data coming from multiple sources and allows the users to jointly query them.
I2b2 data are then stored in a data warehouse, where facts are hierarchically structured as ontologies. Onco-i2b2
gathers data from the FSM pathology unit (PU) database and from the hospital biobank and merges them with
the clinical information from the hospital information system.
Our main effort was to provide a robust integrated research environment, giving a particular emphasis to the
integration process and facing different challenges, consecutively listed: biospecimen samples privacy and
anonymization; synchronization of the biobank database with the i2b2 data warehouse through a series of Extract,
Transform, Load (ETL) operations; development and integration of a Natural Language Processing (NLP) module, to
retrieve coded information, such as SNOMED terms and malignant tumors (TNM) classifications, and clinical tests
results from unstructured medical records. Furthermore, we have developed an internal SNOMED ontology rested
on the NCBO BioPortal web services.
Results: Onco-i2b2 manages data of more than 6,500 patients with breast cancer diagnosis collected between
2001 and 2011 (over 390 of them have at least one biological sample in the cancer biobank), more than 47,000
visits and 96,000 observations over 960 medical concepts.
Conclusions: Onco-i2b2 is a concrete example of how integrated Information and Communication Technology
architecture can be implemented to support translational research. The next steps of our project will involve the
extension of its capabilities by implementing new plug-in devoted to bioinformatics data analysis as well as a
temporal query module.
Background
In the last few years, a noteworthy effort has been
devoted to develop new Information and Communica-
tion Technology (ICT) infrastructures to support biome-
dical research. Such infrastructures have often been
designed to integrate clinical and research data, in order
to accelerate both the process of new discoveries in
basic research, thanks to the rich phenotype information
contained in clinical records, and the translation of
research results in clinical practice.
I np a r t i c u l a r ,t h i si st h ea i mo ft h eI n f o r m a t i c sf o r
Integrating Biology and the Bedside (i2b2) research cen-
ter: i2b2 [1,2] is one of the seven centers funded by the
NIH Roadmap National Centers for Biomedical Com-
puting [3]. Among other important results, i2b2 has
delivered an open source suite, which provides clinical
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tively perform the integration of clinical and biomedical
records. I2b2 is based on a data warehouse, which is
efficiently interrogated to find sets of interesting patients
preserving their privacy through a query tool interface.
Within this architecture, interoperable server-side soft-
ware objects, called “cells”, are able to exchange informa-
tion with each other, relying on web services technology.
The collection of all cells is named “hive” [4].
In order to support and improve the efficiency of clin-
ical research in oncology, the University of Pavia and
the IRCCS Fondazione Salvatore Maugeri of Pavia are
developing and implementing a novel ICT platform,
called Onco-i2b2, grounded on the i2b2 software.
Onco-i2b2 is able to integrate data from different
sources inside the i2b2 data warehouse through the
implementation of a complex IT architecture, which
includes development of new i2b2-cells for data analysis.
As result of this project, hospital researchers have been
enabled to obtain information from the PU database,
from a biobank management system and to merge them
with the clinical information present in the hospital
information system (HIS), in order to select interesting
patients with a specific phenotype of interest.
Currently, the project manages patients with a princi-
pal diagnosis of breast cancer. However, since the oncol-
ogy unit and the biobank of the FSM hospital are
already equipped to handle information about samples
coming from other wards or other European medical
centers, new type of cancers will be considered in the
near future.
Methods
In this section we will describe the design principles and
the implementation of the IT architecture that has been
deployed at the FSM hospital within the Onco-i2b2 pro-
ject. As mentioned in the previous section, our system
is based on the i2b2 open source software environment,
and its main features are briefly summarized below.
An overview of the i2b2 technological solutions
The i2b2 framework has two main pillars: the data
warehouse and the data management services [4].
The data warehouse is called Clinical Research Chart
(CRC). The CRC is a based on a star schema [5], one of
the fundamental data warehouse models. The CRC has
a central “fact” table, called “observation fact”,a n df o u r
“dimension” tables, which represent “patients”, “medical
concepts”, “visits” and “care providers”. The observation
table contains the patient data while the dimension
tables contain further descriptive and analytical informa-
tion about attributes in the observation table. A dimen-
sion table may contain information about how certain
data is organized, such as a hierarchy that can be used
to categorize or summarize the data. Such hierarchies
are exploited to query the data and are referred to as
the “i2b2 ontology” [6].
The data management services are divided into server-
side software modules and client-side applications. The
server-side software objects are called “cells” and they
compose the “hive” of i2b2. Each cell is a web-service
that communicates with the other cells through XML
messages following REST standard [7] over HTTP. The
current i2b2 release provides five necessary cells that
make up the core of the i2b2 hive: File and Data Reposi-
tory, Security, Ontology, and Identity Management. Cur-
rently, two client-side applications are available, a web-
browser access which leverages on Javascript functions
and a desktop Java application, the workbench, based on
the Eclipse platform [4]. Both clients allow the user to
fast query the data by dragging and dropping query con-
cepts from the ontology (i.e. the previously described
hierarchy of the dimensions), which is properly dis-
played. The concepts can be combined using an “and/
or” mode and the query results are saved and may be
exported to other client data analysis modules, which
can be included as “plug-ins”. Thanks to the technology
developed within i2b2 it is possible to integrate informa-
tion coming from different sources and collected for dif-
ferent purposes, in order to enable researchers to query
and analyze the huge amount of data coming from the
clinical practice and to plann further “in silico”, “in
vitro” or “in vivo” investigations.
The Onco-i2b2 system
The main goal of the Onco-i2b2 project is to gather
data and samples, which are collected during the day-
by-day activity of the Oncology I department of the
FSM, and to make them available for research purposes
in an easy, secure and anonymized way. Once a patient
is hospitalized, he/she may sign an informed consent to
donate samples, specimens and data collected for clini-
cal reasons to research. When this happens, the selected
samples, coming from the PU unit, are anonymized and
stored in the FSM biobank. At the same time, the data
of the FSM HIS are collected and matched with the bio-
bank samples, and stored in the i2b2 CRC.
Given the project purposes and needs, we had to
develop a customization of the i2b2 architecture. In par-
ticular, in order to create a robust and safe integrated
environment we had to face different types of problems.
1. Privacy and anonymization
One of the most important issues we addressed is
related to ensuring the anonymity of data processed and
the need to avoid loss of information while we handle
different types of data sources [8]. After considering dif-
ferent solutions [9], in order to ensure de-identification
of biobank samples, we chose to anonymize each cancer
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novel two-dimensional DataMatrix barcode, which does
not include any direct reference to the donor patient
and to implement an automatic procedure to populate
the biobank database with some of the most interesting
information contained in the pathology unit database.
The relation between the pathology unit patient identi-
fier and the novel identifier associated with biobank
samples is saved in a lookup table stored on a database
server located in a dedicated environment.
2. Synchronization of the biobank database with i2b2
The biobank database and the AP database are periodi-
cally synchronized during the day in order to keep bio-
bank samples data constantly updated. Figure 1 explain
in detail the synchronization process. The information
on the biological samples contained in a biobank are
then loaded into the i2b2 data warehouse through a ser-
ies of Extract, Transform, Load operations that involve
data extraction, processing and mapping in the data
warehouse. The ETL activity was performed relying on
the KETTLE software developed within the Pentaho pro-
ject [10,11]. Figure 1 (points 1 and 2) shows the informa-
tion flow described above. To facilitate the data entry
task related to the day-by-day biobank data management
and to reduce the risks of human errors, a dedicated
web-based software was implemented. This software,
developed in Java using the GWT (Google Web Toolkit)
[12] libraries, allows the researcher to keep under control
the information flow between the PU database and the
biobank database. Before a novel bio sample coming
from the PU unit is stored in the biobank, a number of
preparation steps needs to be performed. All the infor-
mation regarding these operations are stored using this
software. Granted users may retrieve the information
related to the donors’ and patient’s informed consent. In
addition it is possible to manage sets of bio samples, cate-
gorizing them through various meta- attributes like pro-
ject, type, creation date or description. These meta-data
are also included in the ETL process and represents addi-
tional information available in the i2b2 system. Finally,
the IT architecture relies on an application devoted to
keep track of the biobank samples’ locations; this is a
third-party web based software that provides useful sam-
ple information such as fridge position, type of material,
permissions related to the patient informed consent. This
information is uploaded in the i2b2 data warehouse and
made visible to the research through a dedicated web
plug-in in the i2b2 web client, called Biobank Info.
3. The i2b2 web client
The i2b2 web client is a web-based interface to the i2b2
hive, which reproduces much of the functionality of the
“ workbench” desktop client through a web browser [4].
The primary advantage of the web client is that software
does not have to be installed on users’ computers. This
allows having an always-updated environment, reducing
maintenance and immediately making available any new
features to all users.
As previously mentioned, the information related to
bio samples can be easily retrived by possible running
the Biobank Info plug-in, located inside the analysis tool
web page and totally compliant with the i2b2 1.5 ver-
sion. By using this plug-in, the researcher can directly
access the biobank samples information related to speci-
fic patient sets previously extracted with ad-hoc queries.
After dragging and dropping a patient set into the
Biobank Info plug-in dedicated box (see Figure 2 for
visible details), the user has to select the type of material
contained in the samples to be searched (possible
choices are visible in Figure 2) in order to view the
requested information.
Figure 1 FSM ICT architecture. The ICT architecture designed to integrate information from the FSM PU, the HIS, the biobank database and
the i2b2 system. Synchronization between de PU and the BB databases occurs periodically every fifteen minutes from 8am to 10pm. As backup
procedure, a differential dump is made every day at midnight and files were stored on separated servers. The anonymization task is performed
during this synchronization process. In the synchronization phase clinical information is retrieved from the FSM HIS for every patient that had at
least one contact with the PU unit. A further ETL process merges all the information once a week and populates the Onco-i2b2 data warehouse.
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The main focus of the Onco-i2b2 project is currently
dealing with breast cancer patients. Onco-i2b2 starts
working when a biopsy is performed to obtain the
detailed diagnosis. The tissue is tested in the pathology
lab and a report is generated. The report contains the
cancer diagnosis including the cancer ‘stages’ or the size
of the cancer region.
Since these reports are only available in textual format,
we developed a NLP software module aimed at extracting
diagnostic information for all cancer patient health
records that have at least one biological sample stored in
the biobank. A large number of applications of the NLP
technology has been presented in the context of the i2b2
project, and a specific cell has been developed, too. See
for example [13]. Since the report is generated automati-
cally as a result of a data entry process made by the PU
unit, it has a pre-defined basic structure and contains
coded texts such as SNOMED [14] terms related to
tumor cells, tissues and organs topology and morphology.
Other coded information automatically retrieved by our
NLP module are related to the TNM [15], which contains
information about the size of the tumor, whether the
tumor has invaded the nearby tissues, the regional lymph
nodes that are involved, the distant metastasis and the
grade of the cancer cells.
The NLP software also retrieves clinical information
related to specific medical tests such as the DAKO Her-
cepTest, which measures the HER-2 (Human Epidermal
growth factor Receptor 2 or c-erbB-2 oncoprotein, a pro-
tein related to breast cancer aggressiveness [16]) and
some hormone receptors, like the estrogens receptors
and progesterone receptors. Positive or negative results
drive the classification of abnormal cells/tissues and pro-
vide a basis for the specific treatment selection. Finally,
the NLP module also retrieves information regarding the
Ki-67 expression [17]. Ki-67 is a cancer antigen that is
expressed during cell growth and division, but is absent
in the cell resting phase. The researchers agreed that a
high level of Ki-67 is a biomarker related to aggressive
tumors with poor prognosis. In fact, in a recent paper
[17] it was found that breast cancers could vary in terms
of hormone-sensitivity, lymph node status (positive or
negative), but if the tumor has high levels of Ki-67, the
risk of recurrence was higher than average.
Our NLP tool is based on the GATE system [18], thus
following a software pipeline, in which each component
has different settings and roles. One of the most impor-
tant components is the sectionizer, which allows divid-
ing the parsing document in categorized sections. We
have configured this component in order to search only
the coded part of the medical report, omitting the parts
Figure 2 Biobank Info plug-in. The Onco-i2b2 Biobank Info plug-in, running on the i2b2 web client application. Using this tailored plug-in is
possible to select which type of biosample is related to one defined patient set.
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the correct section of the document is selected, the tex-
tual analysis is performed with the aim of finding the
possible SNOMED codes, as well as the biomarkers
described above. The software module that perform this
task, based on GATE libraries, relies on a configuration
file that contains the regular expression needed to find
the SNOMED codes and the biomarker values, as well
as a database containing all the SNOMED codes and
their description. As a result of the entire NLP process,
an XML file is generated containing a structured list of
coded values ready to be imported in the i2b2 data
warehouse. See the “Additional file 1“ for the XML
schema of the generated document, “Additional file 2“
for the example of a real medical report and “Additional
file 3“ for the XML resulted from the NLP software
module.
The system has been internally validated by a manual
verification by the medical experts involved in the study
on a subset of 100 cases with 100% accuracy. This mod-
u l ei sn o wac r u c i a lp a r to ft h ee n t i r es o f t w a r e
architecture.
5. Ontologies and the NCBO Bioportal
As mentioned in the overview of the i2b2 technological
solutions, the query interface relies on the definition of a
set of hierarchies of concepts, mapped in the concept
dimension table of the CRC; such hierarchies are referred
to as the i2b2 “ontology”. In order to cope with the needs
of Onco-i2b2 we have composed the ontology by includ-
ing both portions of pre-defined ontologies and a purpo-
sively defined hierarchy of concepts that maps the
information contained in the HIS and in the biobank DB
(i.e. a “internal” ontology).
As concerns the pre-defined ontologies, we wished to
represent information related to SNOMED codes in a
standardized way. For this reason, we relied on the
NCBO BioPortal [19] web services in order to populate
the i2b2 concepts data warehouse dimension. The strat-
egy we adopted was to pull data from NCBO via dedi-
cated REST web services and then reorganize the results
into the format used by the i2b2 ontology cell.
The first step involved the selection of the ontology
named “SNOMED morphologically Abnormal Structure”
(Ontology Id 2058), a sub-tree of the SNOMED CT
ontology that properly maps the information we needed.
Once the BioPortal registration was successfully
obtained, we were able to use the “View Extraction” web
service, which extracts a branch of an ontology given a
root term by iterating over all terms of a sub-tree. We
use as root term a subset of the sub-tree that identifies
neoplasm and hamartoma. The NCBO web service gen-
erates a Web Ontology Language (OWL) file format [20].
Using the ontology OWL file [21], through a Java
based procedure we have processed the information in
order to generate a data structure compliant with the
i2b2 ontology cell.
Figure 3 shows the ONCO-i2b2 ontology and the
hierarchy related to the SNOMED concepts.
Results
The main result of our work is an integrated ICT
infrastructure that leverages on i2b2 to navigate infor-
mation related to samples collected in biobank
together with data derived from clinical practice; this
system allows the FSM researchers to exploit i2b2
query capabilities relying on the user-friendly web
interface available. We also extended the i2b2 web
plug-ins with a tool that can manage information
about patients bio samples.
After a four months period of trial and testing
(December 2010- March 2011) the system is now up
and running and the FSM hospital.
Currently, the i2b2 instance installed in FSM consists
of 6,713 patients related to breast cancer diagnosis (393
of them have at least one biological sample in the can-
cer biobank since December 2010 that is the biobank
operating start date), 47,140 visits, and 96,506 observa-
tions over 960 concepts.
In an effort to continuously improve this i2b2 based
integrated architecture for hospital researchers, our
team has already added two other novel web plug-ins
f o rd a t ae x p o r ta n df o rK a p l a n - M e i e rs u r v i v a la n a l y s i s
[22].
Discussion
T h ee x p e r i e n c eg a i n e dd u r i n go nw i t ht h eO n c o - i 2 b 2
project is likely to have an impact in terms of results
exploitation and generalization of the platform.
First of all, i2b2 is a steadily growing and very active
community of open source software developers and
users. Nowadays, more than 50 centers are part of the
i2b2 academic user community around the world. The
software developed within Onco-i2b2 is made available
to this wide community and potentially used by the
other groups. In particular, the previously mentioned
data export plugin and an R-engine cell for data analysis
have been shared in the community software repository
and downloaded by other groups [23].
Moreover, Onco-i2b2 deals with the important pro-
blem of managing the integration of biobank data and
clinical information, relying on a set of intertwined
modules with different “concerns”. By properly adapting
t h eE T Ll a y e r ,i tw o u l db ep o s s i b l et or e u s et h em o s t
part of the developed solution, with particular reference
to the interface with the biobank database, the CRC, the
client and the plug-ins. The Onco-i2b2 system can be
thus adapted to other research centers dealing with can-
cer patients’ data, with the need to integrate biobank
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of fact, a very interesting research direction is repre-
sented by the Shrine project [24], which aims to define
a cross-institutional collaboration framework to share
data with the i2b2 infrastructure. Onco-i2b2 would per-
fectly fit in this initiative, also allowing the management
of samples in the biobank coming from different hospi-
tals and research groups.
Figure 3 Onco-i2b2 ontology. The Onco-i2b2 ontology hierarchy. The figure highlights the section related to breast cancer SNOMED codes.
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proposed architecture to integrate data from patients
suffering from different diseases. As a matter of fact, the
FSM biobank has been recently upgraded to store blood
samples coming from a variety of clinical departments,
including oncology (for other types of cancer patients),
nephrology, and pneumology.
Conclusions
The design and implementation of an integrated ICT
architecture that is able to merge information related
to different hospital data sources and that can be useful
for medical practice and research is a stimulating
challenge.
The novel IT architecture created at FSM is a con-
crete example of how this type of integration can be
correctly implemented and made available for scientific
research. To achieve this goal we had to face several
challenges: i) the development of a specific software that
allows automatic upload of the information from the PU
to the biobank database; ii) the generation of new anon-
ymized barcodes when the biosamples are stored in the
biobank; iii) the design, development and configuration
of an NLP software module to extract information from
unstructured medical report generated from the PU and
containing information relevant to the clinical character-
ization of patients in cancer research; iv) the creation of
dedicated ETL transformations to populate the i2b2
data warehouse with concepts related to cancer
research. Each ETL process used is a reusable compo-
nent that can be scheduled to perform different data
transformation jobs, once the system will have to deal
with new samples coming from other hospital wards, or
from other hospitals departments of the FSM corporate
network. In a similar manner, the NLP module was
designed to be as modular as possible, to allow its reuse
on other medical reports.
Exploiting the potential of this IT architecture, the
next steps of the project will concern the extension of
the data set imported by the HIS as well as the manage-
ment of other data from the laboratory tests. We also
plan to continue extending the capabilities of the Onco-
i2b2 architecture by implementing new plug-in devoted
to data analysis; in particular, we are working on an
extension of the i2b2 query engine by adding temporal
query capabilities.
Following the example of the experience reported in
[25], the future developments of the project regard the
integration of patient’s genotype data, including Next
Generation Sequencing derived information, which will
require careful evaluation both in terms of the data
representation and storage and of data security and
privacy.
Additional material
Additional file 1: XML Schema for the NLP module output file. PDF file
that represents the XML Schema used to generate the XML result file for the
NLP module. Detailed below are the tags used: <document> is the xml root
container; <name> represents the anonymized report id; <date> is the
report date; <type> inform about histological or cytological type; <number>
is the specimen number related to the report; <estrogens_receptors>,
<progesterone_recoptors>, <Ki67>, <c-erb_B2> are related to laboratory
analysis values, <grade> is the tumor grade, <state> in the TNM tumos code
and <snomed> is a list of <code> and <name> that represent SNOMED
values.
Additional file 2: Medical report example used with the NLP
module. PDF file that represents a real example of medical records used
as input for the developed NLP software module.
Additional file 3: XML example for the NLP module output file.P D F
file that represents the XML format result file of the NLP module. The
explanation of each tag is detailed in the description of “Additional file 1“.
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Ontology Web Language.
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